CKAP2L and colorectal cancer: In addition, CKAP2L has been reported to be associated with disease progression and prognosis in a variety of tumors, including non-small-cell lung cancer, glioblastoma, hepatocellular carcinoma, and colorectal cancer (Xiong et al., 2019; Li et al., 2020; Wang and He, 2020; Feng et al., 2021).